Ruijin Hospital
Ruijin Hospital
Shanghai, Shanghai Municipality, China28 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of Recurrence | Chronic Disease, Digestive System Diseases, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Type 1 Autoimmune Pancreatitis, autoimmune disease, autoimmune pancreatitis, chronic pancreatitis, immune system disorder, pancreas disorder, pancreatitis | Recruiting | Phase 4 | 2026-10-06 | NCT06468709 | |
| Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-09-28 | NCT07844941 | |
| Research on Respiratory Support Decision-Making for Mechanically Ventilated ICU Patients Based on a Physiological World Model | acute respiratory failure | Not yet recruiting | Not stated | 2026-09-22 | NCT07834671 | |
| Breath Gases, Gut Flora, and Immunity in Children With Constipation | Constipation - Functional | Active, not recruiting | Not stated | 2026-09-01 | NCT07797491 | |
| New Genotype-guided Treatment in Newly Diagnosed PTCL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-16 | NCT07706959 | |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A. | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 3 | 2026-07-15 | NCT07229547 | |
| Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma (PDAC) | Recruiting | Not stated | 2026-07-06 | NCT07683845 | |
| Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDS | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, anemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-05-26 | NCT07607418 | |
| Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma | primary central nervous system lymphoma | Not yet recruiting | Phase 2 | 2026-02-12 | NCT07405255 | |
| Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension | resistant hypertension | Not yet recruiting | Phase 3 | 2025-11-18 | NCT07232966 | |
| Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm | Recruiting | Phase 2 | 2025-09-24 | NCT06368141 | |
| Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD. | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2025-09-22 | NCT07184697 | |
| A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL) | B-cell neoplasm, B-cell non-Hodgkin lymphoma, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2025-07-18 | NCT07072169 | |
| Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2025-06-26 | NCT06500208 | |
| Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation | acute myeloid leukemia, myelodysplastic syndrome | Recruiting | Phase 2 / Phase 3 | 2025-05-18 | NCT06972641 | |
| The Application of Somatosensory Interactive Pelvic Floor Muscle Training for Stress Urinary Incontinence in Men Underwent Radical Prostatectomy | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Not applicable | 2025-04-04 | NCT06740071 | |
| Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II) | Bacterial Infections and Mycoses, Infections, Pseudomonas infection, bacterial infectious disease, bronchial disorder, bronchiectasis, gram-negative bacterial infections, respiratory system disorder | Recruiting | Not stated | 2025-04-01 | NCT06760273 | |
| Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 3 | 2025-02-18 | NCT05991908 | |
| Clinical Evaluation of Non-invasive Blood Glucose Meter | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Recruiting | Not applicable | 2025-01-28 | NCT06796322 | |
| Morning Versus Bedtime Dosing of Antihypertensive Medication | cardiovascular disorder, hypertensive disorder, vascular disorder | Recruiting | Phase 4 | 2025-01-06 | NCT05089448 | |
| Registry Study on "Control Nocturnal Hypertension to Reach the Target " | Nocturnal Hypertension | Recruiting | Not stated | 2025-01-06 | NCT04137549 | |
| A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients" | cardiovascular disorder, hypertensive disorder, vascular disorder | Recruiting | Not stated | 2025-01-06 | NCT03547856 | |
| Effect of Belimumab on Antibody Titers in Primary APS Patients | antiphospholipid syndrome, autoimmune disease, immune system disorder | Recruiting | Phase 2 | 2024-12-24 | NCT06747312 | |
| MRD in High-risk EBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not stated | 2024-08-22 | NCT06566729 | |
| The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma | Extranodal Natural Killer T Cell Lymphoma | Not yet recruiting | Phase 3 | 2024-02-13 | NCT06255795 |